Business news from Ukraine


9 April , 2020  

Yuzhny port’s fleet received more than UAH 24 million in income in March 2020, the enterprise’s press service has said.
According to Yuzhny, the figure obtained is 224% of the monthly financial plan. This result of the work was ensured by a large number of ship calls and fire-fighting services for cargo operations at berth No. 3H of Yuzhny port.
Earlier, the port reported that in March 2020 the company handled 1.777 million tonnes of cargo, which exceeds the previous absolute record for a monthly transshipment of 1.650 million tonnes in March 2014 by 127,200 tonnes.
Over the past month, the company accepted 25 vessels, 14 of which are vessels of the Capesize type. The number of large-capacity bulk carriers with a deadweight of more than 150,000 tonnes doubled compared to March 2019.
Darnitsa pharma company purchases hydroxychloroquine, awaits delivery to Ukraine
KYIV. April 8 (Interfax-Ukraine) – Darnitsa pharmaceutical company (Kyiv) purchased hydroxychloroquine for production of medicines and awaits its delivery to Ukraine, Board Chairman of Darnitsa Group Dmytro Shymkiv has said.
“We are already transporting the active substance, namely hydroxychloroquine, to Ukraine. We managed to reserve it for ourselves at a time when most countries closed the export of this substance,” he told Interfax-Ukraine.
Shymkiv said that Darnitsa pharmaceutical company is ready to produce hydroxychloroquine medicines, however, “the main precondition for this is active steps in regulatory matters from the Health Ministry,” he said.
Shymkiv said that Darnitsa specialists studied the experience of treating the coronavirus disease (COVID-19) in China, European countries and the United States, where patients infected with COVID-19 using medicines with hydroxychloroquine are treated as part of clinical trials. Moreover, a precondition for such therapy is the patient’s consent to treatment with the experimental medicine.
“Today, we expect the Health Ministry to follow the measures prescribed in the new laws on health protection and on medicines, which came into force on April 1, 2020. Then we can move on,” he said.
Darnitsa pharmaceutical company is one of the ten largest pharmaceutical manufacturers in Ukraine and the top ten largest hospital suppliers.